Certified by Founder Lodge
Mirador Therapeutics
United States - San Diego, California
START UP
1 Disclosed Funding Rounds $400,000,000
0 Participating Investments
-
Founded date
2024
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mirador is a next-generation precision medicine company focused on immunology and inflammation. The company’s Mirador360 TM precision development engine leverages the latest advances in human
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 26 ,2024 | Unknown | $400,000,000 |
OrbiMed
ARCH Venture Partners
Alexandria Real Estate Equities, Inc.
RTW Investments, LP
Blue Owl Capital
Logos Capital
Boxer Capital, LLC
Farallon Capital Management
Point72
TCGX
Fairmount Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
